Selected Reports from The EASL Conference;
European Association for the Study of the Liver
Rotterdam, April 28-May 3 2000:

• Report 13
  HCV Primer & New Drugs in Development
  
  
• Report 12
  CHRONIC LIVER DISEASE: DIABETES and BONE MASS (EASL abstracts)
  
  
• Report 11
  IFN-RIBAVIRIN COMBINATION THERAPY FOR PATIENTS WITH HCV-RELATED DECOMPENSATED CIRRHOSIS
  
  
• Report 10
  RANDOMIZED, CONTROLLED PILOT TRIAL OF INTERFERON (IFN) WITH OR WITHOUT THYMOSINa1 (TA1) IN NAŠVE CHRONIC HEPATITIS C (CHC)
  
  
• Report 9
  INTERFERON IMPROVES LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C
  
  
• Report 8
  IFN-RIBAVIRIN COMBINATION THERAPY FOR PATIENTS WITH HCV-RELATED DECOMPENSATED CIRRHOSIS
  
  
• Report 7
  Reports on the two pegylated interferons
  
  
• Report 6
  Two Articles on Pegylated Interferon
  
  
• Report 5
  Viral Kinetics and Hard To Treat Populations
  
  
• Report 4
  Sunday Evening Update From EASL
  
  
• Report 3
  EASL Day 2, Sunday
  
  
• Report 2
  EASL Day 1 - Afternoon Meeting
  
  
• Report 1
  EASL Conference Day 1
  
  
• Intro Report
  Intro Report From EASL (European Association for the Study of the Liver)